Counselors in Meredith, NH Accepting Medicare

5 Counselors found. Showing 1 - 5

Ms. Dorothy Ann Derapelian, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 248 Daniel Webster Hwy, Meredith, NH 03253 Phone: 603-279-8169    Fax: 603-279-8169

Ms. Wendy Elise Porter, L.A.D.C Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 56 Circle Dr, Meredith, NH 03253 Phone: 603-455-5203

Ms. Linda M. Brewer, LICSW, MLADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 252 Daniel Webster Hwy., Ste #2, Meredith, NH 03253 Phone: 603-393-6292    Fax: 603-279-5008

Ms. Jennifer L Johnson, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 248 Daniel Webster Hwy, Meredith, NH 03253 Phone: 603-524-7117

Holly Samaha Cedarstrom, LCMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 248 Daniel Webster Highway, Meredith, NH 03253 Phone: 603-279-8209

News Archive

Medidata names EXTEDO as technology partner

Medidata Solutions has further expanded its Partner Program by naming EXTEDO, provider of regulatory information management software and service solutions, a Medidata Technology Partner. EXTEDO created an integration that utilizes Medidata Rave Safety Gateway to transfer critical safety data from Medidata Rave, a leading system for electronic data capture, clinical data management and reporting, into its PcVmanager drug safety management solution.

Antibody kinetics in recovered COVID-19 patients

Researchers from Tel Aviv University have been examining the kinetics of antibodies in recovered COVID-19 patients.

Preventing HPV infection could slow HIV epidemic, say researchers

Men infected with human papillomavirus are at greater risk of becoming infected with human immunodeficiency virus than men who are not HPV positive, according to researchers at the University of North Carolina at Chapel Hill.

Women with inherited BRCA1/2 mutations at increased risk of breast and ovarian cancers

In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.

Read more Medical News

› Verified 4 days ago